Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an announcement.
WuXi AppTec Co., Ltd. has announced the completion of its acquisition of H Shares worth HK$1 billion under the 2025 H Share Award and Trust Scheme. This acquisition is part of a broader strategy to incentivize core employees by using these shares as award shares, contingent upon the company achieving a revenue target of RMB43 billion for 2025. The scheme aims to align employee interests with company performance without diluting existing shareholder interests, although there remains uncertainty about meeting the revenue conditions.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$70.40 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company focuses on providing comprehensive laboratory and manufacturing services to support the pharmaceutical, biotechnology, and medical device industries globally.
Average Trading Volume: 8,222,963
Technical Sentiment Signal: Buy
Current Market Cap: HK$203.8B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.